Hubbry Logo
HaemophilusHaemophilusMain
Open search
Haemophilus
Community hub
Haemophilus
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Haemophilus
Haemophilus
Haemophilus
View on Wikipedia
from Wikipedia
Not to be confused with Haemophilia.

Haemophilus
Haemophilus influenzae on a Chocolate agar plate.
Scientific classification Edit this classification
Domain: Bacteria
Kingdom: Pseudomonadati
Phylum: Pseudomonadota
Class: Gammaproteobacteria
Order: Pasteurellales
Family: Pasteurellaceae
Genus: Haemophilus
Winslow et al. 1917
Species

H. aegyptius
H. ducreyi
H. felis
H. haemoglobinophilus[1]
H. haemolyticus
H. influenzae
H. massiliensis
H. parainfluenzae
H. paracuniculus
H. parahaemolyticus
H. paraphrohaemolyticus[1]
H. piscium[1]
H. pittmaniae
H. seminalis
H. sputorum[1]

Haemophilus is a genus of Gram-negative, pleomorphic, coccobacilli bacteria belonging to the family Pasteurellaceae.[2][3] While Haemophilus bacteria are typically small coccobacilli, they are categorized as pleomorphic bacteria because of the wide range of shapes they occasionally assume. These organisms inhabit the mucous membranes of the upper respiratory tract, mouth, vagina, and intestinal tract.[4] The genus includes commensal organisms along with some significant pathogenic species such as H. influenzae—a cause of sepsis and bacterial meningitis in young children—and H. ducreyi, the causative agent of chancroid. All members are either aerobic or facultatively anaerobic. This genus has been found to be part of the salivary microbiome.[5]

Metabolism

[edit]

Most members of the genus Haemophilus require at least one of these blood factors for growth: hemin (sometimes called 'X-factor') and/or nicotinamide adenine dinucleotide (NAD; sometimes called 'V-factor'); they usually will not grow on blood agar plates. While NAD is released into blood agar by red blood cells, hemin is bound to the blood cells and is unavailable to bacteria in this medium which prevents the growth of many Haemophilus species.[6] They are unable to synthesize important parts of the cytochrome system needed for respiration, and they obtain these substances from the heme fraction of blood hemoglobin. Clinical laboratories use tests for the hemin and NAD requirement to identify the isolates as Haemophilus species.[4] The species Haemophilus haemoglobinophilus is an exception to this, as it has been shown to grow well on both blood and chocolate agars.[7][self-published source?]

Chocolate agar is an excellent Haemophilus growth medium, as it allows for increased accessibility to these factors.[8] Alternatively, Haemophilus is sometimes cultured using the "Staph streak" technique: both Staphylococcus and Haemophilus organisms are cultured together on a single blood agar plate. In this case, Haemophilus colonies will frequently grow in small "satellite" colonies around the larger Staphylococcus colonies because the metabolism of Staphylococcus produces the necessary blood factor byproducts required for Haemophilus growth.

Strain[9] Needs hemin Needs NAD Hemolysis on HB/Rabbit blood
H. aegyptius + + –
H. ducreyi + – –
H. influenzae + + –
H. haemolyticus + + +
H. parainfluenzae – + –
H. parahaemolyticus – + +

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Haemophilus

View on Grokipedia
from Grokipedia
Haemophilus is a of small, Gram-negative, pleomorphic coccobacilli bacteria in the family , distinguished by their fastidious growth requirements for blood-derived factors such as () and NAD (factor V). These nonmotile, aerobic or facultatively anaerobic organisms are typically found in the upper of humans and animals, where they can exist as commensals or opportunistic pathogens. The genus name derives from the Greek words for "blood-loving," reflecting their dependence on heme-containing compounds for cultivation, often requiring enriched media like . Key species within the include Haemophilus influenzae, H. parainfluenzae, and H. ducreyi, each associated with distinct clinical manifestations. H. influenzae is particularly notable for causing invasive s such as , , , and , especially in unvaccinated children, though nontypeable strains commonly lead to respiratory infections like and . While vaccines against H. influenzae type b (Hib) have dramatically reduced invasive type b , nontypeable strains remain a significant cause of respiratory infections as of 2025. H. ducreyi is the etiologic agent of , a sexually transmitted , while H. parainfluenzae can contribute to and lower infections. The cell walls of Haemophilus species contain lipooligosaccharide rather than , which plays a role in their pathogenicity and immune evasion. Taxonomically, Haemophilus species are identified based on their specific nutritional needs: for instance, H. influenzae requires both factors X and V, whereas H. parainfluenzae needs only factor V. Enhanced growth often occurs in a carbon dioxide-enriched atmosphere, underscoring their adaptation to mucosal environments.

Taxonomy and Classification

Etymology

The genus name Haemophilus derives from the Greek haîma (αἷμα), meaning "blood," and philos (φίλος), meaning "loving" or "friend," resulting in "blood-loving" to describe the bacteria's dependence on blood-derived growth factors for cultivation. This nomenclature was formally established by Winslow et al. in 1917 when they proposed the genus to encompass certain hemophilic bacilli previously classified under other names. The type species, , originated from earlier descriptions of influenza-associated bacteria; it was named Bacterium influenzae by Lehmann and Neumann in 1896 based on isolates from respiratory infections. The epithet "influenzae" stems from the Latin genitive of (Italian for "influence," referring to the disease), as the organism was erroneously identified as the primary cause of influenza pandemics in the late 19th century, a misconception first advanced by Richard Pfeiffer in 1892. This association persisted despite later evidence that influenza is viral, leading to the species' reclassification into the Haemophilus genus by Winslow et al. in 1917.

Phylogenetic Position

The genus Haemophilus is classified within the phylum Pseudomonadota, class Gammaproteobacteria, order Pasteurellales, and family Pasteurellaceae. This placement reflects its membership in a diverse group of Gram-negative bacteria primarily associated with mucosal infections in animals and humans. Phylogenetic analyses, particularly those based on 16S rRNA gene sequences, position Haemophilus firmly within the Pasteurellaceae family, highlighting its monophyletic core clade that includes species such as H. influenzae and H. parainfluenzae. These sequences reveal sequence similarities of approximately 93-97% with other Pasteurellaceae members, underscoring shared evolutionary origins while delineating genus boundaries. Evolutionary divergence of Haemophilus from closely related genera like Pasteurella is evidenced by distinct genetic markers, including seven conserved signature indels (CSIs) exclusive to the Haemophilus sensu stricto group and variations in housekeeping genes such as rpoB and infB. Multilocus sequence analysis incorporating these markers confirms polyphyletic tendencies in broader Pasteurellaceae phylogenies but supports the integrity of the core Haemophilus lineage as a distinct evolutionary branch.

Physical and Biochemical Characteristics

Morphology and Structure

Haemophilus species are Gram-negative bacteria exhibiting a coccobacillary morphology, characterized by short, rod-shaped or ovoid cells that appear pleomorphic under the microscope. These bacteria typically measure 0.3–0.5 μm in width and 0.5–1.0 μm in length, with rounded ends that contribute to their coccoid appearance in certain growth conditions. They are non-motile and lack spores, features that distinguish them from many other bacterial pathogens. As Gram-negative organisms, Haemophilus possess a characteristic cell envelope consisting of an inner cytoplasmic membrane, a thin layer in the (approximately 2–10 nm thick), and an outer membrane. The layer provides structural integrity while remaining relatively sparse compared to , allowing flexibility in cell shape. The outer membrane is asymmetric, with phospholipids on the inner leaflet and lipooligosaccharides (LOS) on the outer leaflet; unlike full lipopolysaccharides in other Gram-negatives, LOS in Haemophilus lacks the repeating O-antigen chain, resulting in a shorter structure that influences host immune interactions. Certain Haemophilus strains, particularly encapsulated ones like Haemophilus influenzae type b, produce a polysaccharide capsule surrounding the cell. This capsule is composed of polyribosyl ribitol phosphate (PRP), a repeating polymer of ribose and ribitol-5-phosphate units, which forms a protective slime layer that resists phagocytosis and enhances virulence. Non-encapsulated strains lack this feature but may express other surface structures. Additionally, many Haemophilus isolates bear pili, thin proteinaceous filaments extending from the outer membrane, which mediate adherence to respiratory epithelial cells and mucus, facilitating colonization.

Growth Requirements

Haemophilus species are fastidious characterized by their dependence on specific exogenous growth factors for cultivation . Species in the genus require one or both of (hemin) and the V factor (, NAD+), which are essential for biosynthesis and electron transport, respectively, and are typically obtained from lysed red blood cells in enriched media. Without these factors, Haemophilus cannot grow on unsupplemented , highlighting their obligate parasitic lifestyle adapted to nutrient-limited host environments. Chocolate agar is the standard solid medium for isolating and growing Haemophilus, as heating blood to 80–90°C lyses erythrocytes and releases the bound X and V factors into the medium, supporting colony formation. Similarly, Levinthal's broth, an enriched liquid medium containing , , and other supplements, provides these factors and facilitates broth cultures for susceptibility testing or . Some , such as H. parainfluenzae, require only the V factor and can grow on blood agar, but most pathogenic members like H. influenzae demand both for robust proliferation. Optimal growth of Haemophilus occurs at temperatures of 35–37°C, mimicking conditions, and in a microaerophilic or capnophilic atmosphere with 5–10% CO₂ to enhance factor utilization and prevent . Incubation under these conditions typically yields visible colonies within 24–48 hours on appropriate media, underscoring the importance of precise environmental control for clinical and research applications.

Metabolism

Nutritional Needs

Haemophilus species exhibit specific nutritional dependencies critical for their , particularly an absolute requirement for (X factor) and NAD (V factor). is essential for the synthesis of involved in the , enabling aerobic respiration, as lacks the ability to produce de novo. Similarly, NAD serves as a crucial cofactor in electron transport and other metabolic processes, with the bacterium unable to synthesize it due to the absence of key biosynthetic enzymes in the de novo pathway. These requirements are met in natural host environments through scavenging from host tissues or blood components. Carbon metabolism in Haemophilus primarily relies on simple sugars such as glucose, which is catabolized via respiration-assisted to generate energy and byproducts like . Some strains display auxotrophies for specific , such as , which impacts their growth and survival in nutrient-limited host sites like the . These auxotrophies arise from genetic variations that disrupt biosynthetic pathways, necessitating external supplementation for optimal proliferation. Iron acquisition is vital for Haemophilus pathogens, given the nutrient's role in incorporation and enzymatic functions. Pathogenic species, including nontypeable H. influenzae, employ multiple systems for iron uptake, such as direct scavenging and utilization of host transferrin-bound iron via specific receptors. Additionally, these strains possess loci for utilization, allowing them to exploit iron chelates produced by other microbes or the host, thereby enhancing survival in iron-restricted environments.

Respiratory Pathways

Haemophilus species are facultative anaerobes that primarily generate energy through aerobic respiration, utilizing oxygen as the terminal electron acceptor in their (ETC). The ETC in these involves membrane-bound components, including NADH dehydrogenases and a series of , which facilitate the transfer of electrons from substrates like NADH to oxygen. Key elements include cytochrome oxidases such as cytochromes a₁, o, and bd, which serve as terminal oxidases under aerobic conditions. These heme-derived , along with flavoproteins, form a branched that enhances energy efficiency. The composition of the ETC adapts to environmental oxygen levels; for instance, cytochrome bd oxidase expression increases under microaerobic conditions to maintain respiration. This system supports a process often described as respiration-assisted fermentation, where oxidative phosphorylation complements substrate-level phosphorylation during glucose catabolism. Heme, essential for the synthesis of these cytochrome components, underscores the bacterium's dependency on exogenous sources for optimal respiratory function. Under low-oxygen or anaerobic conditions, Haemophilus shifts to pathways to regenerate NAD⁺, producing end products such as and lactate. is a predominant fermentation product, derived from via phosphate acetyltransferase and kinase, while lactate forms through activity, albeit in smaller quantities. This metabolic flexibility allows survival in oxygen-limited environments, such as host mucosal sites.

Habitat and Ecology

Natural Environments

Haemophilus species are primarily commensal residing on the mucosal surfaces of the upper respiratory and genital tracts in humans and various animals, where they form part of the normal . Despite this host dependency, rare instances of isolation from non-host sources have been documented, though free-living populations in abiotic environments like or remain unestablished. The fastidious nature of Haemophilus severely limits their environmental persistence, as they require specific growth factors such as (factor X) and NAD (factor V), which are typically unavailable outside host tissues. Consequently, these exhibit poor survival in natural non-host settings, with no routine detections reported from or aquatic ecosystems despite targeted sampling efforts. For instance, extensive testing of water sources, including backwaters and lakes, failed to yield H. ducreyi isolates, underscoring their inability to thrive in such habitats. Survival outside hosts is brief and highly sensitive to abiotic factors like and . Haemophilus species can persist in mucous for up to 18 hours and on inert surfaces such as for approximately 12 hours under ambient conditions. This susceptibility to environmental stressors further restricts their distribution beyond host-associated niches.

Host Associations

Haemophilus species are primarily associated with mammalian hosts, where they often exist as commensal or symbiotic bacteria in the upper respiratory tract. Nontypeable Haemophilus influenzae (NTHi), the most common human-associated species, colonizes the nasopharynx and other mucosal surfaces of the upper respiratory tract, beginning in infancy and persisting throughout life in many individuals. Colonization rates increase with age, reaching over 50% in children aged 5–6 years and more than 75% in healthy adults, with transmission occurring via airborne droplets and close contact. This commensal relationship allows NTHi to adhere to epithelial cells using adhesins such as HMW1/HMW2 and Protein E, which bind to extracellular matrix components like laminin, facilitating stable mucosal colonization without typically causing harm in healthy hosts. In veterinary contexts, Haemophilus parasuis exhibits similar host associations with pigs, serving as an early colonizer of the upper respiratory tract in healthy swine. This bacterium is frequently isolated from the nasal passages, tonsils, and trachea of pigs in swine-rearing regions worldwide, establishing a commensal presence that modulates with host immune factors like serum antibodies. Non-virulent strains of H. parasuis contribute to the porcine respiratory microbiome, where they interact with innate defenses such as alveolar macrophages, maintaining a balanced symbiotic dynamic in the absence of stressors. A key mechanism enhancing Haemophilus persistence in these host associations is biofilm formation on mucosal epithelia. NTHi and related species produce adherent biofilms on the apical surfaces of airway epithelial cells, incorporating components like sialylated exopolysaccharides and extracellular DNA to create structured communities up to 20 μm deep. These biofilms promote long-term colonization by reducing susceptibility to host clearance mechanisms and antibiotics, as demonstrated in in vitro models using polarized epithelial monolayers, thereby supporting chronic commensalism in the nasopharynx and porcine airways.

Diversity and Species

List of Recognized Species

The genus Haemophilus currently encompasses approximately 13 recognized species that remain validly published and classified within it, primarily based on 16S rRNA gene sequencing, whole-genome analyses, and phenotypic characteristics such as growth factor requirements (X-factor: hemin; V-factor: NAD), oxidase activity, and hemolysis patterns. These species are fastidious, Gram-negative coccobacilli belonging to the family Pasteurellaceae, with most requiring supplemented media for cultivation. Type strains are typically deposited in culture collections like NCTC (National Collection of Type Cultures) or ATCC (American Type Culture Collection), and distinguishing tests often include satellite growth around Staphylococcus (for V-factor dependency), porphyrin synthesis, and urease activity. Recent taxonomic revisions have reduced the number of species in Haemophilus from over 20 historically named taxa, with several reclassified to new genera like Aggregatibacter (e.g., former H. actinomycetemcomitans, H. aphrophilus, and H. segnis in 2006 based on phylogenetic and chemotaxonomic data) due to distinct genomic signatures and host associations. The following table enumerates the current recognized species in Haemophilus, including key details on host, growth requirements, notable biochemical traits, and type strains. This list reflects updates as of 2025, excluding reclassified taxa.
Species NameOriginal Description (Year, Author)Primary HostGrowth RequirementsKey Biochemical TestsType Strain
H. influenzae(Lehmann and Neumann 1896) Winslow et al. 1917Humans (respiratory tract)X- and V-factors requiredOxidase +, catalase +, non-hemolytic, indole -; 6 capsular serotypes (a-f)NCTC 8143 (ATCC 33391)
H. parainfluenzaeRivers 1922 (Approved Lists 1980)Humans (oropharyngeal)V-factor onlyOxidase +, catalase +, non-hemolytic, indole +NCTC 8479 (ATCC 7901)
H. ducreyi(Augustin 1909) Bergey et al. 1925Humans (genital ulcers)X-factor onlyOxidase + (variable), catalase -, non-hemolytic, urease variable; microaerophilicNCTC 10945 (ATCC 33940)
H. haemolyticus(Thjotta and Boe 1938) Winslow et al. 1940Humans (respiratory)X- and V-factors requiredOxidase +, catalase +, β-hemolytic, often misidentified as H. influenzaeNCTC 10659 (ATCC 33390)
H. parahaemolyticus(Tunnicliff 1942) Breed et al. 1948Humans (pharyngitis)V-factor onlyOxidase +, catalase +, β-hemolytic, urease -NCTC 8477 (ATCC 10046)
H. paraphrohaemolyticusMurphy and Gwynn 1983Humans (respiratory)V-factor onlyOxidase +, catalase +, β-hemolytic; ferments sucroseNCTC 11413 (ATCC 51150)
H. pittmaniaeNørskov-Lauritsen et al. 2005 (validated 2020)Humans (saliva, respiratory)V-factor onlyOxidase +, catalase +, β-hemolytic, urease +; named after Marge PittmanCCUG 57076 (DSM 25380)
H. sputorumNørskov-Lauritsen et al. 2005 (validated 2020)Humans (oral cavity)V-factor onlyOxidase +, catalase +, β-hemolytic; produces acetoinCCUG 57077 (DSM 25381)
H. aegyptius(Trevisan 1889) Pittman and Davis 1950Humans (conjunctiva)X- and V-factors requiredOxidase +, catalase +, non-hemolytic; biovar of H. influenzae but distinct in eye tropismNCTC 8502 (ATCC 11116)
H. felisKilian et al. 1989Cats (respiratory)X- and V-factors requiredOxidase +, catalase +, non-hemolytic, indole -; occasional zoonotic potentialNCTC 10391 (ATCC 49728)
H. pisciumSnieszko 1945 (Approved Lists 1980)Fish (aquatic infections)X-factor onlyOxidase -, catalase variable, non-hemolytic; grows at 22°CNCTC 8372 (ATCC 11137)
H. paracuniculusBoot et al. 1993Rabbits (nasal)X- and V-factors requiredOxidase +, catalase +, non-hemolytic; ferments dulcitolATCC 51786
H. seminalisLi et al. 2020Humans (genital tract/semen)V-factor onlyOxidase +, catalase +, non-hemolyticCGMCC 1.17279 (DSM 110435)
Additional species previously classified in Haemophilus have undergone reclassification based on multilocus and average identity thresholds (>95-96% for genus retention). For instance, H. parasuis (porcine , type strain NCTC 4557) was transferred to Glaesserella parasuis gen. nov., comb. nov. in 2019 due to phylogenetic divergence within . Similarly, H. somnus (bovine ) became Histophilus somni in 2003, reflecting its unique genomic features like a distinct structure. H. haemoglobinophilus (porcine) was reclassified as Canicola haemoglobinophilus gen. nov., comb. nov. in 2021, supported by low 16S rRNA similarity (<97%) to other Haemophilus species. These updates emphasize the genus's ongoing taxonomic refinement, with remaining species sharing >98% 16S rRNA identity.

Notable Pathogenic Species

Haemophilus influenzae type b (Hib) is a capsulated strain responsible for severe invasive infections, particularly in young children prior to the widespread use of conjugate vaccines. In the pre-vaccination era, Hib was the leading cause of bacterial in children under five years of age, accounting for approximately 20,000 cases annually alone, with a case-fatality rate of 3-6% and neurological sequelae in up to 30% of survivors. It also caused other invasive diseases such as , , and , disproportionately affecting unvaccinated populations in developed countries. Globally, before vaccine introduction, Hib invasive disease incidence reached up to 1 in 200 children in some regions, highlighting its epidemiological significance as a major pediatric pathogen. Haemophilus ducreyi is the primary etiologic agent of chancroid, a sexually transmitted genital ulcer disease characterized by painful ulcers and inguinal adenopathy. This bacterium thrives in tropical and subtropical climates, with highest prevalence in sub-Saharan Africa, Southeast Asia, and parts of Latin America, where it contributes to 5-10% of genital ulcers in endemic areas despite global declines due to improved diagnostics and syndromic management. Epidemiological data indicate sporadic outbreaks in the United States among certain high-risk groups, but overall incidence remains low, with underreporting complicating accurate assessment. Unique traits include its fastidious growth requirements and ability to form microcolonies, facilitating transmission during sexual contact in resource-limited settings. Haemophilus parasuis, now classified as Glaesserella parasuis, is a significant veterinary causing Glässer's in swine, manifesting as fibrinous polyserositis, , and primarily in piglets aged 3-8 weeks. This leads to high morbidity and mortality in systems worldwide, with economic losses from reduced growth and treatment costs estimated in millions annually in major pork-producing regions like and . As an opportunistic commensal in the porcine upper , virulent serovars (e.g., 4, 5, and 12) invade systemically under stress conditions such as or . While primarily a swine-specific , rare reports suggest limited zoonotic potential through occupational exposure, though human infections remain unconfirmed and exceptional.

Pathogenesis and Clinical Relevance

Infection Mechanisms

Haemophilus species initiate infection by adhering to host mucosal surfaces, primarily through the action of type IV pili and lipooligosaccharide (LOS). Type IV pili, encoded by the pil gene cluster, facilitate close contact with respiratory epithelial cells, enabling initial colonization in the upper airways. LOS molecules on the bacterial surface interact with host cell receptors, such as CEACAMs, promoting stable attachment and modulating host immune responses to favor bacterial persistence. Following adherence, Haemophilus invades epithelial barriers via actin rearrangements and lipid raft-independent endocytosis, allowing intracellular survival within endolysosomal compartments of bronchial cells. This invasion process is enhanced by fimbriae and capsule expression, which disrupt tight junctions and facilitate transmigration across mucosal layers. Nontypeable Haemophilus influenzae (NTHi) has also been shown to invade choroid plexus epithelial cells in a polar fashion. To evade phagocytosis, encapsulated strains like Haemophilus influenzae type b (Hib) employ a polyribosyl ribitol phosphate capsule that inhibits complement activation and opsonization by neutrophils and macrophages. The capsule sterically hinders antibody binding, reducing uptake by professional and promoting bacteremia. Complementing this, Haemophilus produces IgA1 , an enzyme that cleaves the hinge region of secretory IgA1 antibodies, disrupting immune exclusion at mucosal sites and enabling bacterial escape into deeper tissues. This activity is particularly pronounced in pathogenic strains, correlating with increased colonization efficiency in the nasopharynx. For chronic infections, nontypeable Haemophilus influenzae (NTHi) forms biofilms on mucosal surfaces, structured communities encased in extracellular matrix that shield bacteria from antibiotics and host defenses. Biofilm development is regulated by quorum sensing via autoinducer-2 (AI-2) signals produced by the LuxS enzyme, which coordinates density-dependent gene expression for matrix production and community maturation. These mechanisms contribute to persistence in conditions like otitis media and chronic obstructive pulmonary disease, where biofilms resist clearance and promote recurrent inflammation.

Associated Diseases

Haemophilus influenzae is a major cause of invasive bacterial infections, particularly in children, with H. influenzae type b (Hib) historically responsible for severe diseases such as , , and . These illnesses typically present with symptoms including high fever, , , and altered mental status in cases of ; productive cough, , and for ; and acute respiratory distress, , and for . Transmission occurs primarily through respiratory droplets from coughing or sneezing by infected individuals, with close contact facilitating spread in households or daycare settings. Prior to widespread , Hib caused over 20,000 invasive disease cases annually in the United States, predominantly affecting children under 5 years old. The introduction of Hib conjugate vaccines in the late 1980s led to a dramatic decline in invasive Hib disease, with incidence dropping by more than 99% among U.S. children under 5 years by the mid-1990s, reducing cases from approximately 20 per 100,000 to less than 0.1 per 100,000. Globally, Hib has averted millions of cases and deaths, particularly in low-income regions where the disease burden remains higher without routine . Despite this success, non-typeable H. influenzae (NTHi) persists as a common pathogen in mucosal infections, causing up to 30% of acute episodes in young children worldwide, often presenting with ear pain, fever, and hearing impairment. NTHi also contributes significantly to exacerbations of (COPD), accounting for 20-30% of acute episodes in adults, characterized by worsened , increased production, and dyspnea. Like Hib, NTHi spreads via respiratory droplets and colonizes the upper airways asymptomatically before causing disease during viral co-infections or immune compromise. Haemophilus ducreyi primarily causes , a sexually transmitted prevalent in tropical and subtropical regions. Clinical manifestations include painful s with ragged edges, inguinal , and potential suppuration, leading to complications like scarring or facilitation of transmission if untreated. Transmission occurs through direct skin-to-skin contact during sexual activity, with higher incidence among uncircumcised men and sex workers in endemic areas. Epidemiologically, accounts for 5-10% of s in parts of and , though global surveillance is limited due to diagnostic challenges, resulting in underreporting. In addition to sexual transmission, H. ducreyi causes non-sexually acquired cutaneous ulcers in children in remote tropical communities, presenting as chronic limb lesions.

Diagnosis and Management

Laboratory Identification

Laboratory identification of Haemophilus species typically begins with culture-based methods to isolate the fastidious, gram-negative coccobacilli from clinical samples such as (CSF), blood, or respiratory secretions. Primary isolation is performed on enriched media like , which provides essential growth factors (X factor) and NAD (V factor), with incubation at 35–37°C in 5% CO₂ for 24–48 hours. Colonies appear as small, smooth, opaque, and grayish, often exhibiting a characteristic pungent odor. To enhance selectivity, especially from respiratory specimens contaminated with normal flora, supplemented with bacitracin (e.g., 300 μg/mL) is commonly used, as Haemophilus species are inherently resistant to this while many other are inhibited. A key phenotypic test for confirming H. influenzae is the satellite phenomenon, observed on blood plates. When streaked with a β-hemolytic like Staphylococcus aureus—which releases V factor from lysed red blood cells—H. influenzae colonies grow in a satellite pattern adjacent to the S. aureus streak but not independently, demonstrating its dependence on exogenous V factor while requiring X factor from the medium. This test, combined with X and V factor disk assays (where growth occurs only around XV disks), distinguishes H. influenzae (requiring both factors) from species like H. parainfluenzae (V factor only). Non-growth on media lacking these factors further confirms the . Once isolated, biochemical tests provide species-level identification. Most Haemophilus species are oxidase-positive, detected by a color change on oxidase reagent-impregnated disks, and catalase-positive, shown by bubbling upon hydrogen peroxide addition, aiding differentiation from similar genera like Moraxella. Indole production, assessed via spot tests or broth incubation with tryptophan, varies by biotype: for H. influenzae, positive indole is characteristic of certain biogroups (e.g., biotype IV). Additional tests, such as urease and ornithine decarboxylase, contribute to biotyping schemes, with H. influenzae typically urease-negative and ornithine-variable. Commercial systems like API 20 NE or VITEK may integrate these for automated identification, though manual confirmation is recommended due to occasional misidentification of close relatives like H. haemolyticus. Molecular methods offer rapid and specific detection, particularly for pathogenic strains in sterile sites. (PCR) targeting the bexA , part of the capsule locus, is widely used to identify encapsulated Haemophilus influenzae type b (Hib), with primers amplifying a 343-bp fragment unique to capsular types; its presence confirms encapsulation, while absence indicates non-typeable strains. Real-time PCR assays for H. influenzae-specific genes like fucK, hpd, or sodC further differentiate it from commensal species such as H. haemolyticus, achieving >95% specificity in clinical validation. For broader surveillance, 16S rRNA sequencing or provides definitive identification, especially for non-typeable or rare species. These techniques are particularly valuable in culture-negative cases, such as antibiotic-pretreated samples, and are recommended by guidelines for diagnosis.

Treatment Strategies

The primary treatment for Haemophilus influenzae infections involves antimicrobial , with beta-lactam antibiotics serving as the cornerstone due to their efficacy against susceptible strains. Amoxicillin is often recommended as a first-line oral agent for non-severe infections in both children and adults when susceptibility is confirmed, typically administered at doses of 80-90 mg/kg/day divided every 8-12 hours for children or 500-875 mg every 12 hours for adults. However, beta-lactamase production, mediated by plasmids such as TEM-1, confers resistance in approximately 35% of isolates globally (as of 2023–2024), with regional variations up to 50%, necessitating the use of beta-lactamase-stable alternatives like amoxicillin-clavulanate (Augmentin) or second- and third-generation cephalosporins (e.g., or ) for empirical , particularly in severe cases or regions with higher resistance . Additionally, beta-lactamase-negative but ampicillin-resistant (BLNAR) strains, often due to mutations in penicillin-binding protein 3, comprise 10–30% of resistant isolates in some regions (as of 2024), requiring susceptibility testing for optimal . For invasive infections such as bacteremia or , intravenous third-generation cephalosporins like (50-100 mg/kg/day) are preferred, with treatment durations ranging from 7-14 days depending on the site of infection and clinical response. Vaccination remains the most effective preventive strategy against Haemophilus influenzae type b (Hib) , which historically caused significant morbidity in unvaccinated populations. The first conjugate Hib vaccine, PRP-D (polyribosylribitol phosphate conjugated to toxoid), demonstrated in clinical trials starting in 1987 and was licensed for use in infants in 1990, with widespread routine immunization incorporated into national schedules by the early 1990s. Subsequent vaccines, such as PRP-T (conjugated to toxoid) and HbOC (conjugated to CRM197), achieved over 95% against invasive Hib after a primary series of three doses in infancy, significantly reducing global incidence by up to 99% in vaccinated cohorts and conferring . These vaccines are now standard in pediatric immunization programs worldwide, administered as a four-dose series at 2, 4, 6, and 12-15 months of age, with catch-up vaccination recommended for older children in high-risk settings. Supportive care is essential for managing complications of severe Haemophilus infections, such as , where prompt antibiotic initiation is combined with measures to address , seizures, and . In Hib meningitis, adjunctive therapies include intravenous fluids, corticosteroids like dexamethasone (0.15 mg/kg every 6 hours for 4 days) to reduce , and close monitoring in an intensive care setting to mitigate neurological sequelae, which occur in up to 20% of cases despite treatment. Chemoprophylaxis with rifampin (20 mg/kg once daily for 4 days, maximum 600 mg/day) is recommended by the CDC for all household and close contacts of index Hib cases, regardless of status, to eradicate nasopharyngeal carriage and prevent secondary infections, ideally administered within 24 hours of case identification. For non-Hib strains, prophylaxis is generally not indicated unless multiple cases occur in a setting like a childcare center.

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK8458/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC3993099/
  3. https://www.cdc.gov/hi-disease/php/surveillance/index.html
  4. https://lpsn.dsmz.de/genus/haemophilus
  5. https://doi.org/10.1128/jb.2.5.505-566.1917
  6. https://lpsn.dsmz.de/species/haemophilus-influenzae
  7. https://pmc.ncbi.nlm.nih.gov/articles/PMC2118275/
  8. https://www.pathologyoutlines.com/topic/microbiologyhinfluenzae.html
  9. https://www.microbiologyresearch.org/content/journal/ijsem/10.1099/ijs.0.03043-0
  10. https://www.ncbi.nlm.nih.gov/books/NBK562176/
  11. https://onlinelibrary.wiley.com/doi/10.1002/9780470688618.taw0065
  12. https://pmc.ncbi.nlm.nih.gov/articles/PMC5663868/
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC256999/
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC1482897/
  15. https://pubmed.ncbi.nlm.nih.gov/8825810/
  16. https://stacks.cdc.gov/view/cdc/28557/cdc_28557_DS1.pdf
  17. https://www.dshs.texas.gov/haemophilus-influenza-serotyping
  18. https://pmc.ncbi.nlm.nih.gov/articles/PMC3941224/
  19. https://journals.asm.org/doi/10.1128/jb.101.2.365-372.1970
  20. https://link.springer.com/article/10.1007/BF00410174
  21. https://pmc.ncbi.nlm.nih.gov/articles/PMC278093/
  22. https://pubmed.ncbi.nlm.nih.gov/31933358/
  23. https://deepblue.lib.umich.edu/bitstream/handle/2027.42/63406/153623104773547471.pdf%3Bsequence=1
  24. https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0013091
  25. https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment/haemophilus-parainfluenzae.html
  26. https://www.bu.edu/research/ethics-compliance/safety/rohp/agent-information-sheets/haemophilus-influenzae/
  27. https://www.researchgate.net/publication/379189181_Review_On_Veterinary_Important_Haemophilus_Bacteria
  28. https://pmc.ncbi.nlm.nih.gov/articles/PMC3567431/
  29. https://febs.onlinelibrary.wiley.com/doi/10.1002/1873-3468.12351
  30. https://veterinaryresearch.biomedcentral.com/articles/10.1186/s13567-015-0263-3
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC2662906/
  32. https://journals.asm.org/doi/10.1128/CMR.00103-13
  33. https://doi.org/10.1099/ijsem.0.003730
  34. https://pmc.ncbi.nlm.nih.gov/articles/PMC8482018/
  35. https://wwwnc.cdc.gov/eid/article/22/1/15-0425_article
  36. https://pmc.ncbi.nlm.nih.gov/articles/PMC4696685/
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC7152483/
  38. https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/haemophilus-parasuis
  39. https://pmc.ncbi.nlm.nih.gov/articles/PMC3318474/
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC2668387/
  41. https://pmc.ncbi.nlm.nih.gov/articles/PMC3911862/
  42. https://pubmed.ncbi.nlm.nih.gov/30049648/
  43. https://www.mdpi.com/1422-0067/21/16/5739
  44. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC173880/pdf/641051.pdf
  45. https://pmc.ncbi.nlm.nih.gov/articles/PMC10440118/
  46. https://pmc.ncbi.nlm.nih.gov/articles/PMC98916/
  47. https://pmc.ncbi.nlm.nih.gov/articles/PMC3417564/
  48. https://pmc.ncbi.nlm.nih.gov/articles/PMC2738029/
  49. https://pmc.ncbi.nlm.nih.gov/articles/PMC3417591/
  50. https://www.cdc.gov/hi-disease/about/index.html
  51. https://www.cdc.gov/hi-disease/hcp/clinicians/index.html
  52. https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-8-haemophilus-influenzae.html
  53. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6301a1.htm
  54. https://pubmed.ncbi.nlm.nih.gov/21865721/
  55. https://academic.oup.com/femspd/article/75/4/ftx042/3753446
  56. https://wwwnc.cdc.gov/eid/article/21/10/15-0004_article
  57. https://www.cdc.gov/std/treatment-guidelines/chancroid.htm
  58. https://www.who.int/docs/default-source/documents/publications/laboratory-methods-for-diagnosis-of-meningitis.pdf
  59. https://journals.asm.org/doi/10.1128/cmr.00103-13
  60. https://assets.fishersci.com/TFS-Assets/LSG/manuals/IFU1305.pdf
  61. https://microbenotes.com/satellitism-test/
  62. https://journals.asm.org/doi/10.1128/jcm.41.1.393-396.2003
  63. https://pmc.ncbi.nlm.nih.gov/articles/PMC3147886/
  64. https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-08930-5
  65. https://www.mdpi.com/2079-6382/13/8/761
  66. https://emedicine.medscape.com/article/218271-treatment
  67. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545087/all/Haemophilus_species
  68. https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-025-11438-9
  69. https://journals.asm.org/doi/10.1128/aac.00966-09
  70. https://pmc.ncbi.nlm.nih.gov/articles/PMC1592684/
  71. https://jamanetwork.com/journals/jama/fullarticle/203139
  72. https://www.cdc.gov/mmwr/preview/mmwrhtml/00041736.htm
  73. https://academic.oup.com/jid/article/224/Supplement_4/S321/6378086
  74. https://www.gov.uk/government/publications/haemophilus-influenzae-type-b-hib-revised-recommendations-for-the-prevention-of-secondary-cases/revised-recommendations-for-the-prevention-of-secondary-haemophilus-influenzae-type-b-hib-disease
  75. https://www.rch.org.au/clinicalguide/guideline_index/Contact_prophylaxis_for_invasive_meningococcal_or_Hib_disease/
Add your contribution
Related Hubs
User Avatar
No comments yet.